University Of Rochester
BLOG: Optimizing donor selection in aplastic anemia — evolving trends in transplantation
Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.
Nivolumab regimen halves risk for progression, death in Hodgkin lymphoma
Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.
Olanzapine improves nausea, quality of life more effectively than prochlorperazine
Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.
Operative, nonoperative management of Achilles tendon rupture yielded similar outcomes
Results presented at the American Orthopaedic Foot & Ankle Society Annual Meeting showed operative and nonoperative management are both effective treatment options for Achilles tendon ruptures and yield similar outcomes.
Study reveals 'urgent need' to improve health equity for older adults with cancer
Research has insufficiently addressed the intersection of aging, health disparities and cancer outcomes among older adults, according to study findings published in Journal of the American Geriatrics Society.
Guselkumab brings active psoriatic arthritis into ‘stringent’ control through 2 years
Guselkumab for psoriatic arthritis led to major improvements in joint disease activity, complete skin clearance and other “stringent” endpoints that were maintained through 2 years, according to data published in Clinical Rheumatology.
Yoga improves cancer-related fatigue, insomnia among survivors
CHICAGO — Both yoga and cognitive behavioral therapy helped alleviate insomnia among cancer survivors and led to improvement in cancer-related fatigue, results from a randomized phase 3 study showed.
Active cancer treatment linked to increased risk for sudden cardiac arrest
Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.
‘Exciting time’: Biologic use in moderate to severe lupus rose 45% since 2021
Use of biologics to treat moderate to severe systemic lupus erythematosus increased 45% between 2021 and 2023, according to recent findings from a market analysis conducted by Spherix Global Insights.
Partner, parent, physician, professor: Having it all requires sacrifice, boundaries
Theresa Bingemann, MD, FACAAI, FAAAAI, found a role that was perfect for her. Combining her passion for learning and teaching, the program director of University of Rochester’s Allergy and Immunology Fellowship was a dream career.